Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Generic Drugs Market Forecast 2018-2028 - Visiongain Report

      This image opens in the lightbox

      News provided by

      Visiongain

      03 May, 2018, 13:07 GMT

      Share this article

      Share this article


      LONDON, May 3, 2018 /PRNewswire/ --

      Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico

           (Logo: Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

      Report Details 

      The generic drugs market is estimated at $257.3bn in 2017 and is expected to grow at a CAGR of 7.9% from 2017 to 2028. The generic drugs market is expected to grow at a CAGR of 7.2% in the second half of the forecast period.

      How this report will benefit you
      Read on to discover how you can exploit the future business opportunities emerging in this sector.

      In this brand new 254-page report  you will receive 66 tables and 84 figures- all unavailable elsewhere.

      The 254-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

      By ordering and reading our brand-new report today you stay better informed and ready to act.

      Report Scope 

      • Generic Drugs Market forecasts  from 2018-2028

      • Generic Drugs Regional Market and National Market forecasts from 2018-2028, covering:
      • North America: US & Canada
      • Europe: Germany, UK, France, Italy, Spain, Rest of Europe
      • Asia-Pacific: Japan, Australia, India, China, South Korea, Rest of Asia-Pacific
      • Middle East & Africa: South Africa, Saudi Arabia, U.A.E, Rest of Middle East & Africa
      • Latin America: Brazil, Argentina, Mexico, Rest of Latin America

      • SWOT Analysis and Porter's Five Forces Analysis of the generic drugs market.

      • Assessment of selected leading companies that hold major market shares in the generic drugs market.
      • Teva
      • Novartis (Sandoz)
      • Allergan
      • Mylan
      • Pfizer
      • Abbott
      • Sun Pharma
      • Aspen
      • Fresenius Kabi
      • Sanofi
      • Dr. Reddy's Laboratories
      • Apotex

      Visiongain's study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.

      Buy our report today Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico.

      To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

      Or click on: https://www.visiongain.com/Report/2179/Generic-Drugs-Market-Forecast-2018-2028

      List of Companies Mentioned in the Report 

      Abbott

      AbbVie

      Able Laboratories

      Aché

      Actavis

      Alcon (Novartis)

      Allergan (Actavis)

      Amgen

      Anda Inc

      Apotex

      APP Pharmaceuticals

      Arrow Group (Actavis)

      Ascent Pharmahealth (Actavis)

      ASKA Pharmaceuticals

      Aspen

      AstraZeneca

      Aurobindo

      Auspex Pharmaceuticals

      Bedford Laboratories

      Bergamo (Amgen)

      Biocon

      Bioniche Pharma (Mylan)

      BMP Sunstone (Sanofi)

      Caraco

      Celltrion

      CFR Pharmaceuticals (Abbott)

      Cipla

      Claris

      Dabur Pharma (Fresenius Kabi)

      Daiichi Sankyo

      Dalim BioTech

      Dr Reddy's Laboratory

      Ebewe Pharma (Novartis)

      Eden Biopharm Group

      Egis

      Elder Pharmaceuticals (Torrent Pharmaceuticals)

      Eli Lilly

      Elyson Pharmaceuticals

      EMS Sigma Pharma

      Eon Labs

      Eurofarma Laboratories

      Farmacias Similares

      Fenwal (Fresenius Kabi)

      Forest Laboratories (Actavis)

      Foshan Chanbende Development

      Fougera Pharmaceuticals (Novartis)

      Fresenius Kabi

      Fresenius SE & Co

      Fuji Pharma

      Gavis Pharmaceuticals

      Gedeon Richter

      Genfar S.A (Sanofi)

      Genzyme (Sanofi)

      Gilead Sciences

      GlaxoSmithKline (GSK)

      Greenstone (Pfizer)

      Grupo Sanborns

      Grupo Uriach

      Hexal

      Hospira (Pfizer)

      IDEV Technologies (Abbott)

      Ilsung Pharmaceuticals

      Imperial Credit Private Limited

      InnoPharma Inc

      Itero Biopharmaceuticals

      Janssen

      Javelin Pharmaceuticals (Hospira)

      Johnson & Johnson

      Kmart

      KMS Pharmaceutical

      Kowa Pharmaceuticals

      Krka

      Labesfal Genéricos (Fresenius Kabi)

      Laboratorio Sanderson (Fresenius Kabi)

      Laboratorios Best

      Laboratorios Kendrick (Sanofi)

      Lek (Novartis)

      Lundbeck

      Lupin

      Matrix Laboratories

      Mayne Pharma (Hospira)

      Meda AB

      Medley (Sanofi)

      Merck KGaA

      MN Pharma (Amgen)

      Momenta Pharmaceuticals

      Mylan

      Natco Pharma

      Nexus Pharmaceuticals

      Nichi-Iko

      Nippon Chemiphar

      Novartis (Sandoz)

      Novo Nordisk

      OptiMedica (Abbott)

      Orchid Chemicals & Pharmaceuticals

      Oriel Therapeutics (Novartis)

      Parenteral Drugs India Ltd

      Perrigo

      Pfizer

      Piramal (Abbott Laboratories)

      Pliva (Teva)

      PT Soho Global Health

      Ranbaxy (Sun Pharmaceuticals)

      Ratiopharm

      Rimsa

      Roche

      Sabex (Novartis)

      Sanofi

      Sawai Pharmaceuticals

      Schein Pharmaceutical (Actavis)

      Servier

      Shelys (Aspen)

      Sigma Pharmaceuticals (Aspen)

      Solvay Pharmaceuticals (Abbott)

      Specifar Pharmaceuticals (Actavis)

      St. Jude Medical

      STADA Arzneimittel

      Strides Arcolab

      Sun Pharma

      Synthon

      Taiyo Pharmaceuticals

      Takeda

      Teuto Brasileiro (Pfizer)

      Teva

      The Laboratory of Analytical Services International Ltd

      Towa

      UDL Laboratories

      Uteron Pharma (Actavis)

      Valeant Pharmaceuticals

      Wal-Mart

      Warner Chilcott (Actavis)

      Watson

      Wockhardt

      Wyeth (Pfizer)

      Zentiva (Sanofi)

      Zhejiang Chiral Medicine Chemicals Co. Ltd

      Zhejiang Hisun Pharmaceutical

      Zydus Cadila

      To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.